ASX 200 Market Outlook: Healthcare Rebound Mixed for CSL, PME, SHL

The ASX 200 found some footing on Tuesday after Monday’s shaky start, but conviction remains low with the index still trading under its 200-day average. Sector breadth was mixed and volatility stayed compressed, hinting at indecision ahead of the key December period. Healthcare led the improvement last week, yet its rebound remains patchy, with CSL, PME and SHL moving in different directions. With seasonality set to become more supportive from mid-December, traders will be watching whether this week brings follow-through or a renewed slip in momentum.

View related analysis:

Healthcare Rebound Remains Mixed

ASX 200 Market Snapshot

The Australian share market stabilised on Tuesday after a shaky start to the month.
A bullish inside day and a potential inverted hammer formed, although the ASX 200 cash index remains below its 200-day SMA (5891.8).
The narrow trading range — the smallest in 11 weeks — also highlights a lack of conviction from both sides.
Near-term risks still tilt lower following last week’s swing high, but as discussed in Tuesday’s report, the seasonal case for a Santa rally strengthens from mid-December.
Six of eleven ASX sectors finished lower, led by Information Technology (XIJ) and Utilities (XUJ). Energy (XEJ) and Materials (XMJ) outperformed on the day.
Financials (XFJ) saw selling pressure ease, and CBA continues to hold above 150 and its 20-month EMA — a key level for broader ASX sentiment.

Chart analysis by Matt Simpson - source: ASX, LSEG

ASX 200 Correlations

The 10-day correlation between the financials index and the broader market is effectively zero at -0.11, suggesting the 150 level on CBA may not carry the same weight it once did.
Materials remain well-aligned with the index over the 10-day lookback at 0.73.
Broader risk correlations stay firm, with the ASX 200 tracking closely with the DAX (0.93), Nikkei (0.91) and S&P 500 (0.87).

Chart analysis by Matt Simpson - source: ASX, LSEG

ASX 200 Healthcare (XHJ) Rebound Could be Limited

The healthcare sector (XHJ) posted its best week in eight after finding support above the 2023 low. Near-term oversold conditions helped, but the broader bearish backdrop remains. XHJ has now retraced around half of last week’s bullish engulfing candle, so the next few sessions will show whether buyers can build on this. Seasonality could lend support in the second half of December, but the sector may struggle unless key constituents start to turn higher.

ASX 200 Healthcare sector (XHJ) chart with CSL, Pro Medicus (PME) and Sonic Healthcare (SHL) technical analysis showing bearish trends, key EMAs, swing-high signals and potential SHL breakout – source: TradingView.

Chart analysis by Matt Simpson - source: ASX, LSEG

CSL Retains a Bearish Bias

CSL, the sector heavyweight, remains structurally bearish. The recovery from the October low still looks corrective, with price capped below the September low and the 50-day EMA. Bears will be watching for momentum to roll over towards the 160 target, near the November 2018 low (158.43). A break above 190 would imply a deeper retracement, but the downside target stays intact unless the broader trend changes.

Pro Medicus (PME) Hints at Swing High

PME remains in a downtrend, and Monday produced a bearish engulfing candle around the 50-day and 200-day EMAs — a pattern that often precedes a swing high.

Sonic Healthcare (SHL)

SHL is the only major healthcare name showing early signs of potential outperformance. After a multi-week consolidation, price broke above $22 before forming a bull flag. Momentum extended on Tuesday, hinting at a breakout. Bulls will want to see a clean move above the April low (23.76) and the 200-day EMA (~24) to confirm the trend shift.

View the full economic calendar

-- Written by Matt Simpson

Follow Matt on Twitter @cLeverEdge

From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.

As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.

FOREX.com is a trading name of StoneX Financial Pty Ltd.

The material provided herein is general in nature and does not take into account your objectives, financial situation or needs.

While every care has been taken in preparing this material, we do not provide any representation or warranty (express or implied) with respect to its completeness or accuracy. This is not an invitation or an offer to invest nor is it a recommendation to buy or sell investments.

StoneX recommends you to seek independent financial and legal advice before making any financial investment decision. Trading CFDs and FX on margin carries a higher level of risk, and may not be suitable for all investors. The possibility exists that you could lose more than your initial investment and CFD investors do not own or have any rights to the underlying assets.

It is important you consider our Financial Services Guide and Product Disclosure Statement (PDS) available at www.forex.com/en-au/terms-and-policies/, before deciding to acquire or hold our products. As a part of our market risk management, we may take the opposite side of your trade. Our Target Market Determination (TMD) is also available at www.forex.com/en-au/terms-and-policies/.

StoneX Financial Pty Ltd, Suite 42.01, 264 George Street, Sydney, NSW 2000 (ACN 141 774 727, AFSL 345646) is the CFD issuer and our products are traded off exchange.

Delayed London Stock Exchange (LSE) Data

The London Stock Exchange (LSE) market data displayed or referenced on this website is provided on a delayed basis and is not in real time. The delay period may vary but is typically at least 15 minutes. This data is intended for information purposes only and should not be relied upon for trading, investment, or other financial decisions. We do not guarantee the completeness, reliability, or suitability of the data for any particular purpose. Users should consult real-time data sources and obtain professional advice before making any financial decisions.